Le Lézard
Classified in: Science and technology
Subjects: Conference, Event, Trade Show, Webcast

WNS to Participate at Q4'21 Investor Conferences


WNS (Holdings) Limited (NYSE: WNS), a leading provider of global Business Process Management solutions, today announced that the company will participate at the following calendar Q4 2021 investor conferences:

Berenberg 2021 US CEO Conference

Date:  Tuesday, November 9, 2021

Location:  Virtual

Participants:  Keshav Murugesh, CEO and David Mackey, EVP-Finance & Head of Investor Relations

J.P. Morgan 2021 Ultimate Services Conference

Date:  Thursday, November 18, 2021

Location:  Virtual

Participants:  Sanjay Puria, CFO and David Mackey, EVP-Finance & Head of Investor Relations

Presentation:  8:55 AM (Eastern)

Live audio webcast available on WNS' website at http://ir.wns.com

About WNS

WNS (Holdings) Limited (NYSE: WNS) is a leading Business Process Management (BPM) company. WNS combines deep industry knowledge with technology, analytics and process expertise to co-create innovative, digitally led transformational solutions with over 375 clients across various industries. WNS delivers an entire spectrum of BPM solutions including industry-specific offerings, customer experience services, finance and accounting, human resources, procurement, and research and analytics to re-imagine the digital future of businesses. As of September 30, 2021, WNS had 49,511 professionals across 57 delivery centers worldwide including facilities in China, Costa Rica, India, the Philippines, Poland, Romania, South Africa, Spain, Sri Lanka, Turkey, the United Kingdom, and the United States. For more information, visit www.wns.com.

Safe Harbor Provision

This document includes information which may constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, the accuracy of which are necessarily subject to risks, uncertainties, and assumptions as to future events. Factors that could cause actual results to differ materially from those expressed or implied are discussed in our most recent Form 20-F and other filings with the Securities and Exchange Commission. WNS undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.


These press releases may also interest you

at 17:56
Atmofizer Technologies Inc. (the "Company" or "Atmofizer") issues this news release at the request of the Investment Industry Regulatory Organization of Canada ("IIROC"). Statements made in the news release issued by the Company earlier today,...

at 17:55
Omeros Corporation today confirmed that earlier this month the company submitted to the U.S. Food and Drug Administration (FDA) its response to the Agency's Complete Response Letter (CRL) for narsoplimab in the treatment of hematopoietic stem cell...

at 17:40
Datadog, Inc. , the monitoring and security platform for cloud applications, announced today the appointments of Sean Walters as Chief Revenue Officer and Kerry Acocella as General Counsel, effective immediately. Acocella succeeds Laszlo Kopits, who...

at 17:10
MetaGoons, a pioneering Metaverse ecosystem and development platform, has announced its completion of a $2 million seed round. The company also revealed that it has partnered with Team Pacquiao GG, legendary boxer and Philippines Senator Manny...

at 17:08
Pluribus Technologies Corp.  (the "Company") today announced that it has granted options to purchase up to 788,269 common shares as part of the overall remuneration and incentive program for its directors, officers and employees. The options expire...

at 17:05
Seres Therapeutics, Inc. , a leading microbiome therapeutics company, today announced the publication in the New England Journal of Medicine (NEJM) of data from its Phase 3 ECOSPOR III study evaluating SER-109, an investigational oral microbiome...



News published on 3 november 2021 at 10:05 and distributed by: